BMC Neurology (Apr 2023)

Neutral lipid storage disease with myopathy and myotonia associated to pathogenic variants on PNPLA2 and CLCN1 genes: case report

  • João Igor Dantas Landim,
  • Ian Silva Ribeiro,
  • Eduardo Braga Oliveira,
  • Hermany Capistrano Freitas,
  • Lara Albuquerque Brito,
  • Isaac Holanda Mendes Maia,
  • Daniel Gurgel Fernandes Távora,
  • Cleonisio Leite Rodrigues

DOI
https://doi.org/10.1186/s12883-023-03195-6
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Background Neutral lipid storage disease with myopathy (NLSD-M) is an autosomal recessive disease that manifests itself around the 3rd to 4th decade with chronic myopathy predominantly proximal in the shoulder girdle. Clinical myotonia is uncommon. We will report a rare case of association of pathogenic variants on PNPLA2 and CLCN1 genes with a mixed phenotype of NLSD-M and a subclinical form of Thomsen’s congenital myotonia. Case presentation We describe a patient with chronic proximal myopathy, subtle clinical myotonia and electrical myotonia on electromyography (EMG). Serum laboratory analysis disclosure hyperCKemia (CK 1280 mg/dL). A blood smear analysis showed Jordan’s anomaly, a hallmark of NLSD-M. A genetic panel was collected using next-generation sequencing (NGS) technique, which identified two pathogenic variants on genes supporting two different diagnosis: NLSD-M and Thomsen congenital myotonia, whose association has not been previously described. Conclusions Although uncommon, it is important to remember the possibility of association of pathogenic variants to explain a specific neuromuscular disease phenotype. The use of a range of complementary methods, including myopathy genetic panels, may be essential to diagnostic definition in such cases.

Keywords